Skingenix, Inc.
Clinical trials sponsored by Skingenix, Inc., explained in plain language.
-
New ointment tested for stubborn leg wounds
Disease control CompletedThis small, early-stage study tested whether a topical ointment called MEBO could help heal chronic venous leg ulcers. Fourteen adults with ulcers that had been open for over a month were randomly assigned to use either MEBO or standard wound care for eight weeks. The main goal w…
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New ointment tested for stubborn diabetic foot sores
Disease control CompletedThis small, early-stage study tested whether a topical ointment called MEBO could help heal diabetic foot ulcers. Seven participants with long-lasting ulcers were randomly assigned to use either MEBO or standard wound care for up to eight weeks. The main goal was to see if MEBO w…
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New ointment trial aims to heal stubborn diabetic foot wounds
Disease control CompletedThis study tested whether a topical ointment called MEBO could help heal diabetic foot ulcers better than standard wound care. 75 adults with foot ulcers that had lasted at least 4 weeks were randomly assigned to use either MEBO or standard care for up to 8 weeks. Researchers mea…
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC